Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $354.88 million. The enterprise value is $235.26 million.

Market Cap	354.88M
Enterprise Value	235.26M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

RCKT has 109.19 million shares outstanding. The number of shares has increased by 12.83% in one year.

Current Share Class	109.19M
Shares Outstanding	109.19M
Shares Change (YoY)	+12.83%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	71.29%
Float	87.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	15.79
PB Ratio	1.49
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.10.

Current Ratio	6.12
Quick Ratio	5.90
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-112.39

Financial Efficiency

Return on equity (ROE) is -64.41% and return on invested capital (ROIC) is -37.96%.

Return on Equity (ROE)	-64.41%
Return on Assets (ROA)	-35.14%
Return on Invested Capital (ROIC)	-37.96%
Return on Capital Employed (ROCE)	-81.49%
Weighted Average Cost of Capital (WACC)	7.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	202
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.33% in the last 52 weeks. The beta is 0.52, so RCKT's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-46.33%
50-Day Moving Average	3.92
200-Day Moving Average	3.57
Relative Strength Index (RSI)	36.52
Average Volume (20 Days)	2,043,079

Short Selling Information

The latest short interest is 21.55 million, so 19.74% of the outstanding shares have been sold short.

Short Interest	21.55M
Short Previous Month	19.08M
Short % of Shares Out	19.74%
Short % of Float	24.59%
Short Ratio (days to cover)	7.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-212.64M
Pretax Income	-209.38M
Net Income	-209.38M
EBITDA	-202.46M
EBIT	-212.64M
Earnings Per Share (EPS)	-$1.88

Balance Sheet

The company has $144.38 million in cash and $24.76 million in debt, with a net cash position of $119.62 million or $1.10 per share.

Cash & Cash Equivalents	144.38M
Total Debt	24.76M
Net Cash	119.62M
Net Cash Per Share	$1.10
Equity (Book Value)	238.04M
Book Value Per Share	2.18
Working Capital	125.36M

Cash Flow

In the last 12 months, operating cash flow was -$179.62 million and capital expenditures -$169,000, giving a free cash flow of -$179.79 million.

Operating Cash Flow	-179.62M
Capital Expenditures	-169,000
Depreciation & Amortization	10.18M
Net Borrowing	-1,000
Free Cash Flow	-179.79M
FCF Per Share	-$1.65

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.83%
Shareholder Yield	-12.83%
Earnings Yield	-59.00%
FCF Yield	-50.66%

Analyst Forecast

The average price target for RCKT is $29.54, which is 814.77% higher than the current price. The consensus rating is "Buy".

Price Target	$29.54
Price Target Difference	814.77%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1